1. Signaling Pathways
  2. PI3K/Akt/mTOR
  3. mTOR
  4. mTOR Inhibitors

mTOR Inhibitors

mTOR

mTORC1

mTORC2

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

mTOR Inhibitors, Activators & Modulators
Product Name mTOR mTORC1 mTORC2 Purity
Rapamycin  
mTOR, IC50: 0.1 nM (in HEK293 cells )
  99.94%
Everolimus  
mTOR, IC50: 5-6 nM
  98.79%
Torin 1
mTOR, IC50: 3 nM
mTORC1, IC50: 2-10 nM
mTORC2, IC50: 2-10 nM
>99.0%
MHY1485  
mTORC1
mTORC2
99.86%
AZD-8055
mTOR, IC50: 0.8 nM
    99.19%
MT 63-78  
mTORC1
 
Sapanisertib
mTOR, IC50: 1 nM
    99.06%
Dactolisib
mTOR, IC50: 20.7 nM
    99.13%
Temsirolimus  
mTOR, IC50: 1.76 μM
  99.56%
Vistusertib
mTOR, IC50: 2.81 nM
    98.82%
3BDO
mTOR
    99.67%
PI-103  
mTORC1, IC50: 20 nM
mTORC2, IC50: 83 nM
99.86%
JR-AB2-011    
mTORC2, IC50: 0.36 μM
98.09%
Torin 2
mTOR, IC50: 2.81 nM
mTOR, EC50: 0.25 nM (Cell Assay)
    99.93%
LY3023414
mTOR, IC50: 165 nM
    99.77%
Salidroside
mTOR
    98.63%
Torkinib
mTOR, IC50: 8 nM
mTORC1, IC50: 30 nM
mTORC2, IC50: 58 nM
98.76%
Omipalisib  
mTORC1, Ki: 0.18 nM
mTORC2, Ki: 0.3 nM
99.31%
PF-04691502
mTOR, Ki: 16 nM
    99.64%
OSI-027
mTOR, IC50: 4 nM
mTORC1, IC50: 22 nM
mTORC2, IC50: 65 nM
99.40%
Gedatolisib
mTOR, IC50: 1.6 nM
    99.68%
L-Leucine  
mTORC1
  >98.0%
Deforolimus  
mTOR
  98.46%
Dihydromyricetin  
mTORC1
mTORC2
99.79%
Apitolisib
mTOR, Ki: 17 nM
    98.26%
GDC-0084
mTOR, Ki: 70 nM
    99.28%
Dactolisib Tosylate
mTOR, IC50: 20.7 nM
    99.89%
Voxtalisib
mTOR, IC50: 157 nM
mTORC1, IC50: 160 nM
mTORC2, IC50: 910 nM
99.46%
CC-115
mTOR, IC50: 21 nM
    96.64%
Bimiralisib
mTOR, IC50: 89 nM
    98.90%
PQR620  
mTORC1
mTORC2
98.06%
PP121
mTOR, IC50: 10 nM
    99.08%
mTOR inhibitor-3
mTOR, Ki: 1.5 nM
    98.54%
BGT226 maleate
mTOR
    99.76%
PI-103 Hydrochloride  
mTORC1, IC50: 20 nM
mTORC2, IC50: 83 nM
98.06%
PKI-402
mTOR, IC50: 3 nM
    99.79%
GNE-477
mTOR, Ki: 21 nM
    95.81%
GSK1059615
mTOR, IC50: 12 nM
    >98.0%
ETP-46464
mTOR, IC50: 0.6 nM
    98.01%
GNE-317
mTOR
    99.26%
GDC-0349
mTOR, Ki: 3.8 nM
    98.20%
CZ415
mTOR, pIC50: 8.07
    98.43%
WAY-600
mTOR, IC50: 9 nM
    95.12%
CC-223
mTOR, IC50: 16 nM
    99.43%
WYE-132
mTOR, IC50: 0.19 nM
    98.98%
VS-5584
mTOR, IC50: 37 nM
    98.01%
WYE-354
mTOR, IC50: 5 nM
    >98.0%
PF-04979064
mTOR, Ki: 1.42 nM
    99.75%
HDACs/mTOR Inhibitor 1
mTOR, IC50: 1.2 nM
    99.12%
XL388
mTOR, IC50: 9.9 nM
    98.46%
Arnicolide D
mTOR
    >99.0%
PI3K/mTOR Inhibitor-2
mTOR, IC50: 4.7 nM
    99.45%
Pomiferin
mTOR, IC50: 6.2 μM
    97.36%
GNE-493
mTOR, IC50: 30 nM
    95.12%
CC-115 hydrochloride
mTOR, IC50: 21 nM
    97.22%
PQR-530  
mTORC1
mTORC2
NSC781406
mTOR, IC50: 5.4 nM
    99.91%
WYE-687
mTOR, IC50: 7 nM
   
Palomid 529  
TORC1
TORC2
99.47%
BGT226
mTOR
   
FT-1518  
mTORC1
mTORC2
mTOR inhibitor-2
mTOR, IC50: 7 nM
   
PI3K/mTOR Inhibitor-1
mTOR, IC50: 186 nM
   
WYE-687 dihydrochloride
mTOR, IC50: 7 nM
    >98.0%
Hederacolchiside A1
mTOR
   
Rotundic acid
mTOR
   
(+)-Usnic acid  
mTORC1
mTORC2
>99.0%
PI3Kα/mTOR-IN-1
mTOR, Ki: 10.6 nM